Background: Sensorineural hearing loss due to ototoxic cancer therapy is well established; effects on the vestibular system are unknown. We examined the feasibility of implementing vestibular screens for pediatric cancer survivors exposed to ototoxic agents. The prevalence of screening failures is reported.
Pediatric Vestibular Symptom Questionnaire
Subjective measures, like questionnaires, can be helpful in determining a person's perception of difficulties. Though there are many vestibular questionnaires, most focus on adult populations, like the Dizziness Handicap Inventory (DHI); the few questionnaires that are available for children, such as the DHI for Patient Caregivers, are created to assess children with known vestibular issues, and therefore do not screen for potential vestibular dysfunction or abnormalities. 15, 16 The Pediatric Vestibular Symptom Questionnaire (PVSQ) was subsequently developed to quantify vestibular symptom severity and validated the measure in children 6-17 years of age. 17 The 11-item PVSQ was completed by the participant if he/she was 11 years of age or older; the guardian completed the questionnaire on behalf of the participant if he/she was 10 years old or younger (Supplementary Table S1 ). Each item was to be rated on a scale from 0 to 3, with an optional "Don't know" answer. The total score was an average numeric value for the answer to each question, with higher scores indicating greater symptom severity. A score was significant if it was greater than 0.68.
Modified clinical test of sensory interaction on balance
Assessment of the vestibular system often requires the use of large and expensive equipment that is not portable. Among these, the sensory organization test (SOT) is a functional test that assesses a person's integration of visual, proprioception, and vestibular cues through a series of six conditions. These include standing on a firm platform with eyes open, closed, and with sway-referenced visual field, and then with a sway reference platform with eyes open, closed, and with swayreferenced visual field. Screening tools have been created to allow for ease of administration in various settings. The SOT has been adapted into the MCTSIB and is comprised of four test conditions. Studies testing the reliability and accuracy of the MCTSIB in pediatric participants have found that MCTSIB scores correlated with SOT scores. 18 The MCTSIB was administered after the questionnaire and increase their proprioception of the support surface; however, socks were permissible. The distance between the feet was no wider than 12 inches. If the participant took a step, touched the wall, an object, the clinician, or asked to stop the trial, the trial was terminated and the time of termination was recorded. The participant had up to three trials per condition to maintain balance for 30 sec. After successfully maintaining balance for 30 sec or attempting all three trials for the F I G U R E 1 Patient eligibility and accrual: accrual of participants from 84 consecutive patients who were identified as eligible for enrollment. Factors accounting for patients not approached for enrollment are cited. *RT refers to radiation to the head/neck condition, the participant proceeded to the next condition, until all four conditions were obtained. The average time for each condition was calculated, and each of the average scores were added together for a total score, for a maximum of 120 sec. Based on previous published studies, a score of less than 110 sec was significant, and for the purposes of this study, this score represented a vestibular screening failure. 18 
Dynamic visual acuity
The Dynamic Visual Acuity (DVA) test assesses another aspect of the vestibular system called the vestibulo-ocular reflex (VOR). The VOR is responsible for stabilizing a person's gaze; a dysfunctional VOR would result in blurry vision due to retinal image instability and thus affect a person's visual acuity during head movement. Investigators have assessed the utility of the DVA in children and determined its specificity and sensitivity to be 100% for their pediatric test population. 19 The DVA screen consisted of a test where the participant was seated in 20 feet from a Snellen eye chart, which was placed at eye level for the participant. The participant was allowed to wear eye glasses during this test. To determine the participant's static visual acuity, the participant was asked to read the smallest line, while reading all of the letters correctly. After establishing and recording the line of static visual acuity, the examiner stood behind the participant and rotated his/her head side to side, at a speed of 2 Hz or 240 beats per minute; a metronome was used to ensure the appropriate speed was maintained throughout. To determine the dynamic visual acuity, the participant was again asked to read the smallest line possible in which all of the letters were read correctly, while his/her head was moving. The screen constituted a "pass" if the difference between the static visual acuity and dynamic visual acuity was 2 lines or less. A change of 3 or more lines was considered a screen "fail."
For the purposes of this study, a "vestibular screening failure" is defined as any participant who had at least one significant score or screen fail. In addition to screening failures, data collection from patient charts included gender, age, race, cancer diagnosis, date of diagnosis, number and nature of prior brain surgeries, ototoxic chemotherapy exposures, prior vancomycin and aminoglycoside administrations, and hearing thresholds from the most recent audiogram. Referring to the most recent audiograms, a participant's hearing loss was defined in this protocol utilizing the SIOP (International Society of Pediatric Oncology), an ototoxicity grading scale, to assess cancer therapy induced hearing loss. 12 Hearing loss for this study was defined as a SIOP grade 1 or greater, using the worse grade between the two ears, in the event there was an asymmetric hearing loss.
Statistical methods
Patient demographic and clinical characteristics were presented as mean, medians, SDs, and ranges for continuous variables and frequencies (percentage of group) for the categorical variables. For the purposes of this study, a vestibular screening failure is defined as any participant who had at least one significant score or screening failure.
The prevalence of vestibular screening failures and its 95% confidence interval were calculated. Logistic regression analysis was performed to identify significant risk factors (age, race, gender, diagnosis, radiation therapy, surgery, aminoglycoside exposure, or hearing loss) that may be associated with the development of vestibular screening failure. All analyses were conducted with a two-sided test at a significance level of 0.05 using SAS 9.3 (SAS Institute, Cary, NC). Figure 1 describes the patient eligibility and accrual of the study.
RESULTS
There were 84 eligible participants. A total of 26 (30.9%) were not approached due to either alteration in their scheduled appointments, no team member was available for screening, or the patient was unable to be approached during the appointment. The remaining 58 patients (69%) were approached. There were three patients who were ineligible according to the exclusion criteria and were never enrolled. Only four patients refused to participate. The remaining 51 were consented and enrolled. However, one participant was unable to complete the MCT-SIB Condition 1 screen, and therefore became ineligible to participate in the remainder of the study. Thus, 50 participants were enrolled and completed the screening process; this number represents 59.5% of all eligible patients and 86.2% of all patients approached to participate.
The characteristics of the participants are displayed in Table 1 .
There were 28 males (56%) and 22 females (44%). Participants were divided into the following diagnostic categories: (1) brain tumor (medulloblastoma, astrocytoma, pineoblastoma, ependymoma, etc.) or (2) nonbrain tumor (osteosarcoma, neuroblastoma, ALL, retinoblastoma, etc.) representing 31 (62%) and 19 (38%) participants, respectively. Brain surgery was performed on 31 of the participants (63%).
The mean age of diagnosis was 7.39 years, and the mean age at screening was 13. ative correlation to a brain tumor diagnosis, rather than having a protective effect.
Conversely, in contrast to carboplatin, patients who received cisplatin failed to demonstrate a significant increase in vestibular failure (Table 3) . However, when chemotherapy was categorized and analyzed as "neither cisplatin nor carboplatin" (N = 21), "cisplatin only" (N = 15), "carboplatin only" (N = 10), and "combined cisplatin and carboplatin"
(N = 4), the vestibular failure rates were 57%, 86%, 40%, and 25%, respectively. The findings suggested that participants who received "cisplatin only" have a higher rate of vestibular screening failures (86%)
than those who received "carboplatin only" (40%) (P = 0.028) (data not shown This suggests that the longer interval from treatment to evaluation potentially gives patients the opportunity to adjust to their vestibular abnormality, resulting in improved performance during the vestibular screening procedure.
DISCUSSION
With the high accrual acceptance rate, and the low rate of ineligibility (6.9%), we demonstrated that this vestibular screen process is a feasible tool to implement within an ambulatory clinical setting. These measures were easily completed during a typical clinical appointment, and the entire screen was completed in 15 min. The costs for implementing these screens was relatively low, with supplies that are modest in cost (Snellen eye charts, high-density foam pads, blindfolds). Examination of the prevalence of vestibular screening failures in the pediatric oncology population is warranted due to the negative impact of vestibular dysfunction on gaze stabilization and/or poor postural control. These deficits translate into difficulties in academic areas such as reading, motor development and control, and overall balance. 20 The inability to maintain a stable gaze may significantly impact the patient's capabilities in walking and driving. 21 Thus, vestibular dysfunction could adversely affect education and quality of life for this population.
Participants with a shortened duration between end of treatment and vestibular screening were at increased risk for vestibular failure. The compensatory nature of the vestibular system highlights the potential of rehabilitative services to improve the outcome of this population.
There were clear limitations of this study. Eligible participants were recruited based on their upcoming appointments and availability, and therefore resulted in a nonheterogeneous population. However, by recruiting and screening consecutive patients visiting the institution, we believe this participant recruitment method reduced potential biases. An additional limitation was the sample size, as a larger cohort may potentially have enrolled a more diverse population. Furthermore, the age of the cohort was influenced by the screens utilized to assess vestibular function, as there is a limited number of validated, age-appropriate tools available. Another limitation to this study was missing data, specifically, variables for medication administrations and hearing tests, with a total of eight participants without a documented hearing test. Thus, although we could not demonstrate that the presence of hearing loss was linked to vestibular difficulties, the analysis was complicated by incomplete hearing evaluations on all the patients.
For the DVA screen, poor static visual acuity may have masked vestibular screening fails for as many as three brain tumor participants. These participants had poor visual acuity in that they could only read the third line from the top of the eye chart. Since this screen requires a three-line difference for a failure, these participants all passed the screen. Lastly, there was a large team of professionals for this study. While 40 participants were screened by the same team member, the remaining 10 participants were screened by three other team members. However, no obvious variations were noted by the investigators.
CONCLUSIONS
Survivors of childhood brain tumors and those individuals who received brain surgery are more likely to fail vestibular screening
